Efficacy of metronomic chemotherapy in recurrent cervical cancer
INTRODUCTION: Cervical cancer (CC) accounts for approximately 2.1% of all new malignant neoplasms and 2.6% of cancer-related deaths among women in Poland. Despite preventive measures, advanced or recurrent CC remains a therapeutic challenge, with median overall survival below 12 months in most cases...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Via Medica
2026-04-01
|
| Serie: | Oncology in Clinical Practice |
| Soggetti: | |
| Accesso online: | https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/111569 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
